MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 215 filers reported holding MIRATI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,721,696 | +52.2% | 429,791 | +26.3% | 0.00% | +100.0% |
| Q2 2023 | $12,298,688 | -25.0% | 340,401 | -22.8% | 0.00% | -33.3% |
| Q1 2023 | $16,389,390 | +36.9% | 440,812 | +66.9% | 0.00% | 0.0% |
| Q4 2022 | $11,970,494 | -48.8% | 264,191 | -21.1% | 0.00% | -40.0% |
| Q3 2022 | $23,382,000 | +86.8% | 334,779 | +79.5% | 0.01% | +66.7% |
| Q2 2022 | $12,519,000 | +50.6% | 186,480 | +84.5% | 0.00% | +50.0% |
| Q1 2022 | $8,312,000 | -84.4% | 101,096 | -72.2% | 0.00% | +100.0% |
| Q4 2021 | $53,428,000 | +18.5% | 364,216 | +42.9% | 0.00% | -83.3% |
| Q3 2021 | $45,092,000 | +99.4% | 254,884 | +82.0% | 0.01% | +100.0% |
| Q2 2021 | $22,616,000 | -32.5% | 140,009 | -28.5% | 0.00% | -40.0% |
| Q1 2021 | $33,524,000 | -72.8% | 195,704 | -65.1% | 0.01% | -50.0% |
| Q4 2020 | $123,062,000 | +304.3% | 560,286 | +205.6% | 0.01% | +100.0% |
| Q3 2020 | $30,440,000 | +60.4% | 183,319 | +10.3% | 0.01% | +25.0% |
| Q2 2020 | $18,982,000 | -25.1% | 166,262 | -49.6% | 0.00% | -50.0% |
| Q1 2020 | $25,345,000 | -49.0% | 329,722 | -14.5% | 0.01% | -42.9% |
| Q4 2019 | $49,685,000 | -32.2% | 385,570 | -59.0% | 0.01% | -44.0% |
| Q3 2019 | $73,305,000 | -68.9% | 940,892 | -58.9% | 0.02% | -16.7% |
| Q2 2019 | $235,620,000 | +1757.2% | 2,287,557 | +1221.7% | 0.03% | +500.0% |
| Q1 2019 | $12,687,000 | +276.7% | 173,076 | +118.0% | 0.01% | +150.0% |
| Q4 2018 | $3,368,000 | -76.1% | 79,400 | -73.5% | 0.00% | -60.0% |
| Q3 2018 | $14,111,000 | +101.4% | 299,600 | +110.8% | 0.01% | +150.0% |
| Q2 2018 | $7,005,000 | +121.3% | 142,100 | +37.8% | 0.00% | +100.0% |
| Q1 2018 | $3,166,000 | +83.5% | 103,089 | +9.1% | 0.00% | 0.0% |
| Q4 2017 | $1,725,000 | +3.9% | 94,500 | -33.4% | 0.00% | – |
| Q3 2017 | $1,660,000 | +802.2% | 141,870 | +180.9% | 0.00% | – |
| Q2 2017 | $184,000 | -45.1% | 50,509 | -21.7% | 0.00% | – |
| Q1 2017 | $335,000 | +104.3% | 64,479 | +86.7% | 0.00% | – |
| Q4 2016 | $164,000 | -45.3% | 34,527 | -37.2% | 0.00% | – |
| Q2 2016 | $300,000 | -39.6% | 54,974 | +136.9% | 0.00% | – |
| Q1 2016 | $497,000 | -74.9% | 23,201 | -63.0% | 0.00% | -100.0% |
| Q4 2015 | $1,983,000 | -54.8% | 62,745 | -50.7% | 0.00% | -50.0% |
| Q3 2015 | $4,385,000 | +110.7% | 127,400 | +92.7% | 0.00% | – |
| Q2 2015 | $2,081,000 | – | 66,123 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $116,595,216 | 81.37% |
| ORACLE INVESTMENT MANAGEMENT INC | 201,400 | $7,488,052 | 7.25% |
| Paradigm Biocapital Advisors LP | 1,396,779 | $51,932,243 | 4.92% |
| Octagon Capital Advisors LP | 750,000 | $27,885,000 | 4.01% |
| Boxer Capital, LLC | 2,000,000 | $74,360 | 3.65% |
| Artal Group S.A. | 1,537,709 | $57,172 | 3.40% |
| Avoro Capital Advisors LLC | 5,555,555 | $206,555,535 | 3.06% |
| RTW INVESTMENTS, LP | 3,643,114 | $135,450,979 | 2.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 244,000 | $9,071,920 | 2.53% |
| Kynam Capital Management, LP | 499,853 | $18,584,535 | 2.40% |